bioRxivMolecular Biology
Genome-wide specificity profiles of CRISPR-Cas Cpf1 nucleases in human cells
Benjamin P Kleinstiver, Shengdar Q Tsai, Michelle S Prew, Nhu T Nguyen, Moira M Welch, Jose M Lopez, Zachary R McCaw, Martin J Aryee, J. Keith Joung
Abstract
CRISPR-Cas Cpf1 nucleases have recently been described as an alternative genome-editing platform1, yet their activities and genome-wide specificities remain largely undefined. Here we show that two Cpf1 nucleases function robustly in human cells with on-target efficiencies comparable to those of the widely used Streptococcus pyogenes Cas9 (SpCas9)2-5. We also demonstrate that four to six bases at the 3 end of the short CRISPR RNA (crRNA) used to program Cpf1 are insensitive to single base mismatches but that many of the other bases within the crRNA targeting region are highly sensitive to single or double substitutions. Consistent with these results, GUIDE-seq and targeted deep sequencing analyses of two Cpf1 nucleases revealed no detectable off-target cleavage for over half of 20 different crRNAs we examined. Our results suggest that the two Cpf1 nucleases we characterized gen ...
- organism: human
- assay: CRISPR screen
- research focus: variant effect prediction
- research focus: variant calling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancement of Target Specificity of CRISPR-Cas12a by Using a Chimeric DNA-RNA Guide
- Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1
- The Kinetic Basis Of CRISPR-Cas Off-Targeting Rules
Misha Klein, Behrouz Eslami-Mossallam, … Martin Depken·bioRxiv·May 30, 2017
- Multiplex genome editing of human pluripotent stem cells using Cpf1
Haiting Ma, Rudolf Jaenisch·BIO-PROTOCOLPeer-reviewed·Jan 1, 2024
- Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
Stephen K. Jones, John A. Hawkins, … Ilya J. Finkelstein·Nature BiotechnologyPeer-reviewed·Sep 7, 2020
- Engineered Cpf1 Enzymes with Altered PAM Specificities
Linyi Alex Gao, David B.T. Cox, … Feng Zhang·Nature BiotechnologyPeer-reviewed·Jun 5, 2017